(Q40729379)

23 September 2017

Extracellular domain of TGFbeta type III receptor inhibits angiogenesis and tumor growth in human cancer cells (English)

1 reference

23 September 2017

Abhik Bandyopadhyay

1

1 reference

23 September 2017

Yong Zhu

2

1 reference

23 September 2017

Shazli N Malik

3

1 reference

23 September 2017

Jeffrey Kreisberg

4

1 reference

23 September 2017

Michael G Brattain

5

1 reference

23 September 2017

Eugene A Sprague

6

1 reference

23 September 2017

Jian Luo

7

1 reference

23 September 2017

Fernando López-Casillas

8

1 reference

23 September 2017

L-Z Sun

9

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

23 September 2017

1 reference

23 September 2017

21

1 reference

23 September 2017

22

1 reference

23 September 2017

3541-3551

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1205439

23 September 2017

0 references

cites work

Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor-beta

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

Heterogeneity of human colon carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

Expression of transforming growth factor beta (TGFbeta) type III receptor restores autocrine TGFbeta1 activity in human breast cancer MCF-7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor beta growth arrest program

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

Angiogenesis in cancer, vascular, rheumatoid and other disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

Enhanced Tumor Growth of Both Primary and Established Human and Murine Tumor Cells in Athymic Mice After Coinjection With Matrigel

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

Differential effects of laminin, intact type IV collagen, and specific domains of type IV collagen on endothelial cell adhesion and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

Expression of scatter factor in human bladder carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-beta receptor system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

Phenotypic modulation of endothelial cells by transforming growth factor-beta depends upon the composition and organization of the extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

Tumor suppressor activity of the TGF-beta pathway in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

The transforming growth factor-beta family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

TGFbeta signaling in growth control, cancer, and heritable disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

Transforming growth factor beta and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

Metastasis from human breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

Expression of transforming growth factor beta type III receptor suppresses tumorigenicity of human breast cancer MDA-MB-231 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

Potentiation of metastatic capacity by transforming growth factor-beta 1 gene transfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

Transforming growth factor beta 1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

7 January 2021

Ligand binding and functional properties of betaglycan, a co-receptor of the transforming growth factor-beta superfamily. Specialized binding regions for transforming growth factor-beta and inhibin A

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

7 January 2021

Anti-angiogenesis: new concept for therapy of solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

7 January 2021

Excessive production of transforming growth-factor beta 1 can play an important role in the development of tumorigenesis by its action for angiogenesis: validity of neutralizing antibodies to block tumor growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1205439

1 reference

Dimensions Publication ID

23 September 2017

0 references

1 reference